1.
Clin Case Rep
; 9(2): 751-754, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33598239
RESUMO
Serum sickness, a reaction presenting with a classic triad (fever, rash, myalgia/arthralgia), is considered as a rare adverse event following monoclonal antibodies and specifically following treatment with rituximab. This report describes a case of serum sickness in a newly treated young male patient with rituximab for pemphigus vulgaris.